XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net loss $ (70,279) $ (55,029)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 11,886 10,200
Amortization of deferred sales commissions 21,829 13,965
Stock-based compensation 49,444 28,074
Allowance for credit losses 1,011 517
Accretion of marketable securities (3,431) 0
Non-cash operating lease expense 3,012 3,101
Unrealized loss on strategic investments 1,793 0
Other 633 252
Changes in operating assets and liabilities:    
Accounts receivable 16,524 3,356
Prepaid expenses and other assets 505 1,243
Deferred contract costs (30,036) (27,381)
Accounts payable, accrued expenses and other liabilities (14,899) (22,034)
Content costs payable (206) (2,652)
Operating lease liabilities (3,436) (3,146)
Deferred revenue 9,246 33,099
Net cash used in operating activities (6,404) (16,435)
Cash flows from investing activities:    
Purchases of marketable securities (125,968) 0
Proceeds from maturities of marketable securities 139,000 0
Purchases of property and equipment (243) (699)
Capitalized software costs (6,385) (6,643)
Purchases of strategic investments 0 (5,000)
Net cash provided by (used in) investing activities 6,404 (12,342)
Cash flows from financing activities:    
Net proceeds from exercise of stock options 4,710 3,831
Proceeds from share purchases under employee stock purchase plan 4,757 5,563
Payment of deferred offering costs 0 (1,586)
Net cash provided by financing activities 9,467 7,808
Effect of foreign exchange rates on cash flows (25) (4)
Net increase (decrease) in cash, cash equivalents and restricted cash 9,442 (20,973)
Cash, cash equivalents and restricted cash—Beginning of period 317,314 536,768
Cash, cash equivalents and restricted cash—End of period 326,756 515,795
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 323,227 512,166
Restricted cash, non-current 3,529 3,629
Total cash, cash equivalents and restricted cash 326,756 515,795
Supplemental disclosures of cash flow information:    
Interest paid 568 10
Income taxes paid 990 388
Supplemental disclosure of non-cash investing and financing activities:    
Stock-based compensation in capitalized costs 4,768 2,646
Change in unrealized loss on marketable securities $ 202 $ 0